Truxton Corporation Announces Quarterly Cash Dividend

(Other OTC:TRUX),(OTC US:TRUX), NASHVILLE, Tenn., Oct. 23, 2025 (GLOBE NEWSWIRE) — Truxton Corporation (OTCID: TRUX), a financial holding company and the parent of Truxton Trust Company, announced that its Board of Directors has approved a quarterly cash dividend of $0.50 per common share payable December 24, 2025, to shareholders of record as of December 10, […]

Mercurity Fintech Chief Strategy Officer Highlights Digital Asset Treasury Solutions at European Blockchain Convention 11

(NasdaqGM:MFH), New York, NY, Oct. 23, 2025 (GLOBE NEWSWIRE) — Mercurity Fintech Holding Inc. (the “Company,” “we,” “us,” or “MFH”) (Nasdaq: MFH), a blockchain-powered fintech group, today announced that Wilfred Daye, the Company's Chief Strategy Officer (“CSO”), participated as a featured speaker at European Blockchain Convention 11 (EBC11), one of Europe's premier blockchain industry events,

Synfini Selected for SLAS 2026 Innovation AveNEW Showcase

MENLO PARK, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Synfini, Inc., provider of the industry's most innovative Agile AI Foundry for drug discovery, today announced it has been chosen for the prestigious Innovation AveNEW showcase at the Society for Laboratory Automation and Screening (SLAS) 2026 International Conference and Exhibition. Hosted annually by SLAS, the Innovation

Kratos Awarded Single Award $68.3 Million Contract to Build Next-Generation Hypersonic Materials Testing Center

(NASDAQ:KTOS), SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in defense, national security, and global markets, announced today that it has been awarded a contract through the Department of War's Industrial Base Analysis and Sustainment Program to design and build a state-of-the-art mid-tier arc

MasterClass Launches Certificate Course with X, The Moonshot Factory: Breakthrough Innovation Strategy

Professionals can enroll in the course now to learn moonshot thinking and the strategic, systems-level approach used to incubate world-changing ventures like Waymo, Wing and Google Brain MasterClass, the streaming platform where anyone can learn from the world's best, today launched Breakthrough Innovation Strategy: From Bold Idea to Business Impact, a new MasterClass Certificates course

Greentown Labs Announces Go Build 2026 with Amazon, in Collaboration with the Global CO Initiative

The open-innovation program requests applications from leading startups with CO-mineralization technologies for concrete-aggregate production Greentown Labs, the world's largest climatetech and energy incubator, today announced Greentown Go Build 2026-an open-innovation program with Amazon and the Global COInitiative (GCI) at the University of Michigan aimed at accelerating collaborations with startups in the field of CO utilization.

Opsera Unveils Next-Generation AI-Powered DevOps Platform with Hummingbird AI Reasoning Agents, ‘Insights in a Box,’ and GitHub MCP Integration

Industry's first AI Reasoning Agent and fully AI-powered DevOps platform deliver intelligence, scale and enterprise-grade control Opsera Inc., the leader in AI-powered DevOps platforms, today unveiled its next-generation platform, establishing itself as the industry's first end-to-end AI-driven DevOps solution. The release introduces the breakthrough Hummingbird AI Reasoning Agent, “Insights in a Box” for instant actionable

Finance Trailblazer Donna Gambrell Receives 2025 Ned Gramlich Lifetime Achievement Award for Responsible Finance

Opportunity Finance Network gives its highest honor to Gambrell for her career-long commitment to expanding economic opportunity in rural, urban, and Native communities through community development finance Last night, Opportunity Finance Network (OFN), the nation's leading network and intermediary focused on community development investment, presented Donna Gambrell with the 2025 Ned Gramlich Lifetime Achievement Award

Currax Pharmaceuticals LLC to Provide CONTRAVE® at No Cost to Federal Employees During Government Shutdown

Program ensures continued access to treatment for patients enrolled in the Federal Employee & Retirees Health Plan (FEP) Currax Pharmaceuticals LLC, a specialty pharmaceutical company and the manufacturer of CONTRAVE® (naltrexone HCl/bupropion HCl), today announced it will provide CONTRAVE® at no cost to eligible federal employees covered under the Federal Employee and Retirees Plan (FEP)

ABRYSVO Receives Expanded Public Funding Across Canadian Provinces for 2025-2026 RSV Season

Pfizer Canada is pleased to announce that ABRYSVO, its vaccine for the prevention of Respiratory Syncytial Virus (RSV), has been selected for public funding in multiple provinces and territories across Canada for the 2025-2026 season. This milestone reflects growing recognition of the burden RSV places on older adults and the importance of proactive immunization strategies.

Scroll to Top